Posts

Showing posts with the label Europe Veterinary Pharmaceuticals Market 2028

Europe Veterinary Pharmaceuticals Market Is Likely To Up Demand At A USD 9.0 Billion By 2028

Image
  San Francisco, 1 Feb 2022:   The Report  Europe Veterinary Pharmaceuticals Market  Size, Share & Trends Analysis Report By Animal Type, By Product, By Mode Of Administration, By End-use, By Country, And Segment Forecasts, 2021 - 2028 The Europe veterinary pharmaceuticals market size is expected to reach USD 9.0 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.8% from 2021 to 2028. The key factors anticipated to fuel the market growth include increasing demand for companion animal products, pet expenditure, the prevalence of diseases in companion as well as livestock animals, and initiatives by the market players. For instance, in September 2020, Boehringer Ingelheim collaborated with the Fraunhofer Institute for Molecular Biology and Applied Ecology IME to develop sustainable veterinary antiparasitics that are safe and effective. The COVID-19 pandemic significantly impacted the market leading to bottlenecks in

Europe Veterinary Pharmaceuticals Market To Expand Industry Growth At USD 9.0 Billion By 2028

Image
  San Francisco, 12 Nov 2021:   The Report  Europe Veterinary Pharmaceuticals Market  Size, Share & Trends Analysis Report By Animal Type, By Product, By Mode Of Administration, By End-use, By Country, And Segment Forecasts, 2021 - 2028 The Europe veterinary pharmaceuticals market size is expected to reach USD 9.0 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.8% from 2021 to 2028. The key factors anticipated to fuel the market growth include increasing demand for companion animal products, pet expenditure, the prevalence of diseases in companion as well as livestock animals, and initiatives by the market players. For instance, in September 2020, Boehringer Ingelheim collaborated with the Fraunhofer Institute for Molecular Biology and Applied Ecology IME to develop sustainable veterinary antiparasitics that are safe and effective. The COVID-19 pandemic significantly impacted the market leading to bottlenecks i